Research and development of new traditional Chinese medicine (TCM) for "preventive treatment of diseases" and innovation of TCM.
10.19540/j.cnki.cjcmm.20250310.603
- Author:
Rui-Ting LYU
1
;
Yan-Ling AI
1
;
Zhong-Qi YANG
2
;
Ting WANG
3
;
Jian-Yuan TANG
4
Author Information
1. Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610072, China Chengdu University of Traditional Chinese Medicine Chengdu 610072, China.
2. the First Affiliated Hospital of Guangzhou University of Chinese Medicine Guangzhou 510405, China.
3. Beijing University of Chinese Medicine Beijing 100029, China.
4. Hospital of Chengdu University of Traditional Chinese Medicine Chengdu 610072, China.
- Publication Type:English Abstract
- Keywords:
full lifecycle evaluation;
health management;
new drug research and development;
preventive treatment of disease;
traditional Chinese medicine innovation
- MeSH:
Humans;
Drugs, Chinese Herbal/therapeutic use*;
Medicine, Chinese Traditional/methods*;
Pharmacy Research
- From:
China Journal of Chinese Materia Medica
2025;50(13):3589-3595
- CountryChina
- Language:Chinese
-
Abstract:
In the development of traditional Chinese medicine(TCM), the concept of "preventive treatment of disease" has a long history and plays a crucial role in bridging the past and the future. With the continuous growth of public health needs and the ongoing transformation of the registration management of TCM, its position in the research and development of new drugs has become increasingly significant. As one of the important sources of new drug innovation, the new TCM for "preventive treatment of diseases" represents a new thinking proposed based on the current routine registration and research and development. The research and development of TCM for "preventive treatment of diseases" mainly cover four stages: prevention(before the onset of disease), early intervention(when the disease is about to occur), interruption and reversal(when the disease has already occurred), and prevention of recurrence after recovery(after the disease). This study aims to comprehensively analyze the positioning, key points, and difficulties in the research and development of TCM for "preventive treatment of diseases" and explore effective paths to promote the innovative development of TCM through relevant cases. The research and development of new TCM for "preventive treatment of disease" require researchers to seize the opportunities for innovation before the start of the research and development, accurately grasp the key issues at different stages, and pay attention to the full lifecycle evaluation of the drugs. Meanwhile, in the design of the research plan, the optimal effectiveness evaluation indicators should be explored; key and difficult areas such as chronic diseases and rare diseases should be taken seriously, and the limitations of new drug development only based on the diagnosed diseases should be broken, so as to cater to more patients. In addition, through relevant representative cases in China and abroad, the unique advantages of TCM for "preventive treatment of diseases" should be fully leveraged. By learning from the past, all aspects of key points in the evaluation of new drug research and development should be strengthened. Finally, this study proposed that TCM for "preventive treatment of diseases" can employ novel methods and advanced technologies such as new biomarkers and innovative clinical design protocols, as well as new perspectives on disease research and health management. This can provide new paths for the innovation of TCM and public health management.
